Fig. 2: CRBN is not associated with the BLM-induced increase in TGF-β levels.

a, b The TGF-β1/2 level in BALF was determined via multiplex bead assays (control n = 3; BLM-treated mice, n = 4). The data are presented as the mean ± standard error. CRBN cereblon, BLM bleomycin, TGF-β transforming growth factor beta, BALF bronchoalveolar lavage fluid.